Rose-bengal-conjugated gold nanorods for invivo photodynamic and photothermal oral cancer therapies

Biomaterials

Volumn 35, Issue 6, 2014, Pages 1954-1966

  Wang, Beike ^a   Wang, Jia Hong ^a   Liu, Qian ^a   Huang, Hao ^a,b   Chen, Ming ^a   Li, Kaiyang ^a   Li, Chengzhang ^a   Yu, Xue Feng ^a,b   Chu, Paul K ^b  

^a WUHAN UNIVERSITY   (China)

^b CITY UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Gold nanorods; Oral cancer; Photodynamic therapy; Photothermal therapy; Rose bengal

Indexed keywords

CELL DEATH; DISEASES; GAS GENERATORS; GOLD; INFRARED DEVICES; NANORIBBONS; NANORODS; OXYGEN; PLASMONS;

GOLD NANOROD; ORAL CANCER; PHOTODYNAMIC EFFICACY; PHOTODYNAMIC THERAPY (PDT); PHOTOTHERMAL THERAPY; REACTIVE OXYGEN SPECIES; ROSE BENGAL; SINGLET OXYGEN GENERATION;

PHOTODYNAMIC THERAPY;

GOLD NANOPARTICLE; NANOROD; REACTIVE OXYGEN METABOLITE; ROSE BENGAL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INCIDENCE; CANCER MORTALITY; CANCER SIZE; CELL DEATH; CELL VIABILITY; CHEEK POUCH; CONTROLLED STUDY; CYTOTOXICITY; DRUG SAFETY; DRUG UPTAKE; HAMSTER MODEL; HUMAN; HUMAN CELL; HYDROPHILICITY; HYPERTHERMIC THERAPY; IN VITRO STUDY; IN VIVO STUDY; LIGHT; MALE; MOUTH CARCINOMA; MOUTH SQUAMOUS CELL CARCINOMA; NICK END LABELING; NONHUMAN; PHOTODEGRADATION; PHOTODYNAMIC THERAPY; PHOTOTHERMAL THERAPY; PHOTOTOXICITY; PRIORITY JOURNAL; SURFACE PLASMON RESONANCE; THERAPY EFFECT; TUMOR VOLUME;

CRICETINAE;

GOLD NANORODS; ORAL CANCER; PHOTODYNAMIC THERAPY; PHOTOTHERMAL THERAPY; ROSE BENGAL;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CRICETINAE; GOLD; HUMANS; HYPERTHERMIA, INDUCED; IN SITU NICK-END LABELING; MALE; MESOCRICETUS; MOUTH NEOPLASMS; NANOTUBES; PHOTOCHEMOTHERAPY; REACTIVE OXYGEN SPECIES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84890197157     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.11.066     Document Type: Article

References (81)

1. Jemal A., Siegel R., Xu J., Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010, 60:277-300.
2. Bauman J.E., Michel L.S., Chung C.H. New promising molecular targets in head and neck squamous cell carcinoma. Curr Opin Oncol 2012, 24:235-242.
3. Ferlay J., Shin H.R., Bray F., Forman D., Mathers C., Parkin D.M. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010, 127:2893-2917.
4. Hopper C., Kübler A., Lewis H., Tan I.B., Putnam G. mTHPC-mediated photodynamic therapy for early oral squamous cell carcinoma. Int J Cancer 2004, 111:138-146.
5. Raber-Durlacher J.E., Weijl N.I., Abu Saris M., de Koning B., Zwinderman A.H., Osanto S. Oral mucositis in patients treated with chemotherapy for solid tumors: a retrospective analysis of 150 cases. Support Care Cancer 2000, 8:366-371.
6. Leemans C.R., Braakhuis B.J., Brakenhoff R.H. The molecular biology of head and neck cancer. Nat Rev Cancer 2011, 11:9-22.
7. Dickerson E.B., Dreaden E.C., Huang X., El-Sayed I.H., Chu H., Pushpanketh S., et al. Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice. Cancer Lett 2008, 269:57-66.
8. Sultan R.A. Tumour ablation by laser in general surgery. Laser Med Sci 1990, 5:185-193.
9. Mckenzie A.L., Carruth J.A. Lasers in surgery and medicine. Phys Med Biol 1984, 29:619-641.
10. Svaasand L.O., Gomer C.J., Morinelli E. On the physical rationale of laser induced hyperthermia. Lasers Med Sci 1990, 5:121-128.
11. Brunetaud J.M., Mordon S., Maunoury V., Beacco C. Non-PDT uses of lasers in oncology. Lasers Med Sci 1995, 10:3-8.
12. Fang J., Chen Y.C. Nanomaterials for photohyperthermia: a review. Curr Pharm Des 2013, 19:6622-6634.
13. Zhang Z., Wang J., Chen C. Gold nanorods based platforms for light-mediated theranostics. Theranostics 2013, 3:223-238.
14. Choi W.I., Kim J.Y., Kang C., Byeon C.C., Kim Y.H., Tae G. Tumor regression invivo by photothermal therapy based on gold-nanorod-loaded, functional nanocarriers. ACS Nano 2011, 5:1995-2003.
15. von Maltzahn G., Park J.H., Agrawal A., Bandaru N.K., Das S.K., Sailor M.J., et al. Computationally guided photothermal tumor therapy using long-circulating gold nanorod antennas. Cancer Res 2009, 69:3892-3900.
16. Shen S., Tang H., Zhang X., Ren J., Pang Z., Wang D., et al. Targeting mesoporous silica-encapsulated gold nanorods for chemo-photothermal therapy with near-infrared radiation. Biomaterials 2013, 34:3150-3158.
17. Xiao Y., Hong H., Matson V.Z., Javadi A., Xu W., Yang Y., et al. Gold nanorods conjugated with doxorubicin and cRGD for combined anticancer drug delivery and PET imaging. Theranostics 2012, 2:757-768.
18. Ren F., Bhana S., Norman D.D., Johnson J., Xu L., Baker D.L., et al. Gold nanorods carrying paclitaxel for photothermal-chemotherapy of cancer. Bioconjug Chem 2013, 24:376-386.
19. Chen R., Wang X., Yao X., Zheng X., Wang J., Jiang X. Near-IR-triggered photothermal/photodynamic dual-modality therapy system via chitosan hybrid nanospheres. Biomaterials 2013, 34:8314-8322.
20. Jang B., Park J.Y., Tung C.H., Kim I.H., Choi Y. Gold nanorod-photosensitizer complex for near-infrared fluorescence imaging and photodynamic/photothermal therapy invivo. ACS Nano 2011, 5:1086-1094.
21. Wang J., Zhu G., You M., Song E., Shukoor M.I., Zhang K., et al. Assembly of aptamer switch probes and photosensitizer on gold nanorods for targeted photothermal and photodynamic cancer therapy. ACS Nano 2012, 6:5070-5077.
22. Kim J.Y., Choi W.I., Kim M., Tae G. Tumor-targeting nanogel that can function independently for both photodynamic and photothermal therapy and its synergy from the procedure of PDT followed by PTT. JControl Release 2013, 171:113-121.
23. Kuo W.S., Chang Y.T., Cho K.C., Chiu K.C., Lien C.H., Yeh C.S., et al. Gold nanomaterials conjugated with indocyanine green for dual-modality photodynamic and photothermal therapy. Biomaterials 2012, 33:3270-3278.
24. Liopo A., Conjusteau A., Tsyboulski D., Ermolinsky B., Kazansky A., Oraevsky A. Biocompatible gold nanorod conjugates for preclinical biomedical research. JNanomed Nanotechnol 2012, S2:001.
25. Liopo A.V., Conjusteau A., Konopleva M., Andreeff M., Oraevsky A.A. Laser nanothermolysis of human leukemia cells using functionalized plasmonic nanoparticles. Nano Biomed Eng 2012, 4:66-75.
26. Kirui D.K., Krishnan S., Strickland A.D., Batt C.A. PAA-derived gold nanorods for cellular targeting and photothermal therapy. Macromol Biosci 2011, 11:779-788.
27. Huang X., El-Sayed I.H., Qian W., El-Sayed M.A. Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. JAm Chem Soc 2006, 128:2115-2120.
28. CS R., Kumar J., V R., M V., Abraham A. Laser immunotherapy with gold nanorods causes selective killing of tumour cells. Pharmacol Res 2012, 65:261-269.
29. Lee E., Hong Y., Choi J., Haam S., Suh J.S., Huh Y.M., et al. Highly selective CD44-specific gold nanorods for photothermal ablation of tumorigenic subpopulations generated in MCF7 mammospheres. Nanotechnology 2012, 23:465101.
30. Choi J., Yang J., Bang D., Park J., Suh J.S., Huh Y.M., et al. Targetable gold nanorods for epithelial cancer therapy guided by near-IR absorption imaging. Small 2012, 8:746-753.
31. Black K.C., Yi J., Rivera J.G., Zelasko-Leon D.C., Messersmith P.B. Polydopamine-enabled surface functionalization of gold nanorods for cancer cell-targeted imaging and photothermal therapy. Nanomedicine (Lond) 2013, 8:17-28.
32. Wang J., Dong B., Chen B., Jiang Z., Song H. Selective photothermal therapy for breast cancer with targeting peptide modified gold nanorods. Dalton Trans 2012, 41:11134-11144.
33. Gou M., Men K., Zhang J., Li Y., Song J., Luo S., et al. Efficient inhibition of C-26 colon carcinoma by VSVMP gene delivered by biodegradable cationic nanogel derived from polyethyleneimine. ACS Nano 2010, 4:5573-5584.
34. Jang B., Park S., Kang S.H., Kim J.K., Kim S.K., Kim I.H., et al. Gold nanorods for target selective SPECT/CT imaging and photothermal therapy invivo. Quant Imaging Med Surg 2012, 2:1-11.
35. Jin H., Yang P., Cai J., Wang J., Liu M. Photothermal effects of folate-conjugated Au nanorods on HepG2 cells. Appl Microbiol Biotechnol 2012, 94:1199-1208.
36. Huff T.B., Tong L., Zhao Y., Hansen M.N., Cheng J.X., Wei A. Hyperthermic effects of gold nanorods on tumor cells. Nanomedicine (Lond) 2007, 2:125-132.
37. Li Z., Huang P., Zhang X., Lin J., Yang S., Liu B., et al. RGD-conjugated dendrimer-modified gold nanorods for invivo tumor targeting and photothermal therapy. Mol Pharm 2010, 7:94-104.
38. Yang X., Liu X., Liu Z., Pu F., Ren J., Qu X. Near-infrared light-triggered, targeted drug delivery to cancer cells by aptamer gated nanovehicles. Adv Mater 2012, 24:2890-2895.
39. Wang J., Sefah K., Altman M.B., Chen T., You M., Zhao Z., et al. Aptamer-conjugated nanorods for targeted photothermal therapy of prostate cancer stem cells. Chem Asian J 2013, 8:2417-2422.
40. Huang Y.F., Sefah K., Bamrungsap S., Chang H.T., Tan W. Selective photothermal therapy for mixed cancer cells using aptamer-conjugated nanorods. Langmuir 2008, 24:11860-11865.
41. Jerjes W., Hamdoon Z., Hopper C. Photodynamic therapy in the management of potentially malignant and malignant oral disorders. Head Neck Oncol 2012, 4:16.
42. Taber S.W., Fingar V.H., Coots C.T., Wieman T.J. Photodynamic therapy using mono-L-aspartyl chlorin e6 (Npe6) for the treatment of cutaneous disease: a phase I clinical study. Clin Cancer Res 1998, 4:2741-2746.
43. Barr H., Krasner N., Boulos P.B., Chatlani P., Bown S.G. Photodynamic therapy for colorectal cancer: a quantitative pilot study. Br J Surg 1990, 77:93-96.
44. Bown S.G., Rogowska A.Z., Whitelaw D.E., Lees W.R., Lovat L.B., Ripley P., et al. Photodynamic therapy for cancer of the pancreas. Gut 2002, 50:549-557.
45. Kato H., Konaka C., Kawate N., Nishimiya K., Saito M., Kinoshita K., et al. Endoscopic photodynamic diagnosis and therapy with the laser in esophageal, stomach and lung cancer. Internist (Berl) 1985, 26:675-687.
46. Gandin E., Lion Y., Van de Vorst A. Quantum yield of singlet oxygen production by xanthene derivatives. Photochem Photobiol 1983, 37:271-278.
47. Redmond R.W., Gamlin J.N. Acompilation of singlet oxygen yields from biologically relevant molecules. Photochem Photobiol 1999, 70:391-475.
48. Zhao T., Shen X., Li L., Guan Z., Gao N., Yuan P., et al. Gold nanorods as dual photo-sensitizing and imaging agents for two-photon photodynamic therapy. Nanoscale 2012, 4:7712-7719.
49. Fischer E., Varga F. Hepatic storage and biliary excretion of rose bengal in the rat. Acta Physiol Acad Sci Hung 1979, 54:89-94.
50. Uppal A., Jain B., Gupta P.K., Das K. Photodynamic action of rose bengal silica nanoparticle complex on breast and oral cancer cell lines. Photochem Photobiol 2011, 87:1146-1151.
51. Lin W., Garnett M.C., Davis S.S., Schacht E., Ferruti P., Illum L. Preparation and characterisation of rose bengal-loaded surface-modified albumin nanoparticles. JControl Release 2001, 71:117-126.
52. Srivastava S.K., Modak M.J. Rose bengal mediated inhibition of DNA polymerases: mechanism of inhibition of avian myeloblastosis virus reverse transcriptase under photooxidative conditions. Biochemistry 1983, 22:2283-2288.
53. Du G.F., Li C.Z., Chen H.Z., Chen X.M., Xiao Q., Cao Z.G., et al. Rose bengal staining in detection of oral precancerous and malignant lesions with colorimetric evaluation: a pilot study. Int J Cancer 2007, 120:1958-1963.
54. Wang J.H., Wang B., Liu Q., Li Q., Huang H., Song L., et al. Bimodal optical diagnostics of oral cancer based on Rose Bengal conjugated gold nanorod platform. Biomaterials 2013, 34:4274-4283.
55. Sau T.K., Murphy C.J. Seeded high yield synthesis of short Au nanorods in aqueous solution. Langmuir 2004, 20:6414-6420.
56. Huang J., Jackson K.S., Murphy C.J. Polyelectrolyte wrapping layers control rates of photothermal molecular release from gold nanorods. Nano Lett 2012, 12:2982-2987.
57. Ghosh S.K., Nath S., Kundu S., Esumi K., Pal T. Solvent and ligand effects on the localized surface plasmon resonance (LSPR) of gold colloids. JPhys Chem B 2004, 108:13963-13971.
58. Sardar R., Heap T.B., Shumaker-Parry J.S. Versatile solid phase synthesis of gold nanoparticle dimers using an asymmetric functionalization approach. JAm Chem Soc 2007, 129:5356-5357.
59. Pasparakis G. Light-induced generation of singlet oxygen by naked gold nanoparticles and its implications to cancer cell phototherapy. Small 2013, Available from: URL:. http://www.ncbi.nlm.nih.gov/pubmed/23813944.
60. Roper D.K., Ahn W., Hoepfner M. Microscale heat transfer transduced by surface plasmon resonant gold nanoparticles. JPhys Chem C 2007, 111:3636-3641.
61. Hessel C.M., Pattani V.P., Rasch M., Panthani M.G., Koo B., Tunnell J.W., et al. Copper selenide nanocrystals for photothermal therapy. Nano Lett 2011, 11:2560-2566.
62. Redhead H.M., Davis S.S., Illum L. Drug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: invitro characterisation and invivo evaluation. JControl Release 2001, 70:353-363.
63. Panzarini E., Inguscio V., Dini L. Timing the multiple cell death pathways initiated by Rose Bengal acetate photodynamic therapy. Cell Death Dis 2011, 2:e169.
64. Li N., Chen X., Liao J., Yang G., Wang S., Josephson Y., et al. Inhibition of 7,12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamsters by tea and curcumin. Carcinogenesis 2002, 23:1307-1313.
65. Yi D.K., Sun I.C., Ryu J.H., Koo H., Park C.W., Youn I.C., et al. Matrix metalloproteinase sensitive gold nanorod for simultaneous bioimaging and photothermal therapy of cancer. Bioconjug Chem 2010, 21:2173-2177.
66. Liberman A., Wu Z., Barback C.V., Viveros R., Blair S.L., Ellies L.G., et al. Color doppler ultrasound and gamma imaging of intratumorally injected 500 nm iron-silica nanoshells. ACS Nano 2013, 7:6367-6377.
67. Sato Y., Hatakeyama H., Hyodo M., Akita H., Harashima H. Development of an efficient short interference RNA (siRNA) delivery system with a new pH-sensitive cationic lipid. Yakugaku Zasshi 2012, 132:1355-1363.
68. Li X., Chen Y., Wang M., Ma Y., Xia W., Gu H. Amesoporous silica nanoparticle-PEI-fusogenic peptide system for siRNA delivery in cancer therapy. Biomaterials 2013, 34:1391-1401.
69. Huang Z., Dong L., Chen J., Gao F., Zhang Z., Chen J., et al. Low-molecular weight chitosan/vascular endothelial growth factor short hairpin RNA for the treatment of hepatocellular carcinoma. Life Sci 2012, 91:1207-1215.
70. Wang C., Tao H., Cheng L., Liu Z. Near-infrared light induced invivo photodynamic therapy of cancer based on upconversion nanoparticles. Biomaterials 2011, 32:6145-6154.
71. Huang X., Peng X., Wang Y., Wang Y., Shin D.M., El-Sayed M.A., et al. Areexamination of active and passive tumor targeting by using rod-shaped gold nanocrystals and covalently conjugated peptide ligands. ACS Nano 2010, 4:5887-5896.
72. Lee J.Y., Kim K.S., Kang Y.M., Kim E.S., Hwang S.J., Lee H.B., et al. Invivo efficacy of paclitaxel-loaded injectable in situ-forming gel against subcutaneous tumor growth. Int J Pharm 2010, 392:51-56.
73. Ghosh S., Dutta S., Gomes E., Carroll D., D'Agostino R., Olson J., et al. Increased heating efficiency and selective thermal ablation of malignant tissue with DNA-encased multiwalled carbon nanotubes. ACS Nano 2009, 3:2667-2673.
74. Gustafson J., Greish K., Frandsen J., Cappello J., Ghandehari H. Silk-elastinlike recombinant polymers for gene therapy of head and neck cancer: from molecular definition to controlled gene expression. JControl Release 2009, 140:256-261.
75. Goldberg E.P., Hadba A.R., Almond B.A., Marotta J.S. Intratumoral cancer chemotherapy and immunotherapy: opportunities for nonsystemic preoperative drug delivery. JPharm Pharmacol 2002, 54:159-180.
76. Ta H.T., Dass C.R., Dunstan D.E. Injectable chitosan hydrogels for localised cancer therapy. JControl Release 2008, 126:205-216.
77. Rossi C.R., Mocellin S., Pilati P., Foletto M., Quintieri L., Palatini P., et al. Pharmacokinetics of intraperitoneal cisplatin and doxorubicin. Surg Oncol Clin N Am 2003, 12:781-794.
78. Chvapil M. Inhibition of breast adenocarcinoma growth by intratumoral injection of lipophilic long-acting lathyrogens. Anticancer Drugs 2005, 16:201-210.
79. Bao A., Phillips W.T., Goins B., Zheng X., Sabour S., Natarajan M., et al. Potential use of drug carried-liposomes for cancer therapy via direct intratumoral injection. Int J Pharm 2006, 316:162-169.
80. Nishikawa M., Hashida M. Pharmacokinetics of anticancer drugs, plasmid DNA, and their delivery systems in tissue-isolated perfused tumors. Adv Drug Deliv Rev 1999, 40:19-37.
81. Jain R.K., Baxter L.T. Mechanisms of heterogeneous distribution of monoclonal antibodies and other macromolecules in tumors: significance of elevated interstitial pressure. Cancer Res 1988, 48:7022-7032.